PSP94 Inhibitors
Chemical inhibitors of PSP94 can exert their inhibitory effects through various cellular pathways. Andrographolide, for example, targets the NF-κB signaling pathway, which is central to the inflammatory response and can regulate the activity of proteins like PSP94. By inhibiting NF-κB, andrographolide can reduce PSP94 activity due to the attenuated inflammatory signaling. Similarly, the LY294002 and Wortmannin chemicals target the phosphoinositide 3-kinases (PI3Ks), leading to reduced PSP94 activity by interfering with downstream signaling events. PD98059 and U0126 are both inhibitors of MEK within the MAPK/ERK pathway, which influences PSP94 activity. Their mechanism of inhibition of MEK results in a reduction in PSP94's functional activity by affecting the pathway's signaling cascade.
Other inhibitors like SB203580 and SP600125 target different MAP kinase pathways, specifically p38 MAPK and c-Jun N-terminal kinase (JNK), respectively. SB203580's inhibition of p38 MAPK can decrease PSP94 activity by modulating stress response pathways, while SP600125 can lead to decreased PSP94 activity by inhibiting JNK and thus dampening inflammatory responses. Rapamycin inhibits the mTOR pathway, which is involved in protein synthesis and function, and by this action can indirectly inhibit the activity of PSP94. Genistein acts as a tyrosine kinase inhibitor and can decrease PSP94 activity by affecting key signaling pathways. Triciribine's inhibition of AKT also contributes to a decrease in PSP94 activity by disrupting the PI3K/AKT pathway. Finally, flavonoid compounds such as Chrysin and Apigenin can inhibit kinases and protein kinase C (PKC) respectively; these inhibitions can lead to a decreased activity of PSP94 by altering the cellular signaling that regulates its function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Andrographolide is a labdane diterpenoid known to inhibit NF-κB activation. PSP94 is implicated in inflammatory responses where NF-κB plays a central role. Inhibition of NF-κB by andrographolide can lead to a decrease in PSP94 activity due to the dampened inflammatory signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3Ks). Since PI3K signaling can regulate a variety of cellular processes including those related to PSP94, inhibiting PI3K can decrease PSP94 activity by reducing the downstream signaling events that facilitate its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. PSP94 activity can be influenced by the MAPK/ERK pathway, and thus inhibiting MEK with PD98059 can reduce PSP94's functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. The p38 MAPK pathway is involved in stress responses that can regulate the activity of proteins like PSP94. Inhibiting this pathway with SB203580 can decrease the functional activity of PSP94. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which modulates inflammatory responses. PSP94 can be regulated by inflammatory signals, and thus inhibition of JNK by SP600125 can lead to decreased PSP94 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By inhibiting PI3K, wortmannin can reduce the PSP94 activity as it interferes with the signaling pathways that are responsible for PSP94's function in the cell. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. Since PSP94 is influenced by MAPK/ERK signaling, using U0126 to inhibit MEK can lead to a reduction in PSP94 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the PI3K/AKT/mTOR pathway, a pathway known to regulate protein synthesis and function. By inhibiting mTOR, rapamycin can indirectly inhibit the activity of PSP94 by disrupting the pathways that control its function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can affect multiple signaling pathways, including those that regulate PSP94. By inhibiting specific tyrosine kinases, genistein can lead to a decrease in PSP94 activity. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine is an inhibitor of AKT, a serine/threonine-specific protein kinase that is involved in the PI3K/AKT pathway. Inhibition of AKT by triciribine can lead to reduced activity of PSP94 as the pathways that control its function are disrupted. | ||||||